Generic name: granisetron hydrochloride 1mg
Dosage form: tablet, film coated; oral solution
Medically reviewed on July 7, 2017.
The recommended adult dosage of oral KYTRIL (granisetron hydrochloride) is 2 mg once daily or 1 mg twice daily. In the 2 mg once-daily regimen, two 1 mg tablets or 10 mL of KYTRIL Oral Solution (2 teaspoonfuls, equivalent to 2 mg of granisetron) are given up to 1 hour before chemotherapy. In the 1 mg twice-daily regimen, the first 1 mg tablet or one teaspoonful (5 mL) of KYTRIL Oral Solution is given up to 1 hour before chemotherapy, and the second tablet or second teaspoonful (5 mL) of KYTRIL Oral Solution, 12 hours after the first. Either regimen is administered only on the day(s) chemotherapy is given. Continued treatment, while not on chemotherapy, has not been found to be useful.
Use in the Elderly, Renal Failure Patients or Hepatically Impaired Patients
No dosage adjustment is recommended (see CLINICAL PHARMACOLOGY: Pharmacokinetics).
Radiation (Either Total Body Irradiation or Fractionated Abdominal Radiation)
The recommended adult dosage of oral KYTRIL is 2 mg once daily. Two 1 mg tablets or 10 mL of KYTRIL Oral Solution (2 teaspoonfuls, equivalent to 2 mg of granisetron) are taken within 1 hour of radiation.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Kytril (granisetron)
- Kytril Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 2 Reviews
- Drug class: 5HT3 receptor antagonists
- Kytril (Granisetron Injection)
- Kytril (Granisetron Oral Solution)
- Kytril (Granisetron Tablets)
- Kytril (Advanced Reading)